Dr. Olaf Hardt Lecture at Molecular Med Tri-Con 2016: Tumor Cell Isolation

Watch Dr. Olaf Hardt from Miltenyi Biotec R&D Oncology team describe a novel workflow for isolating pure ‪‎tumor‬ cell populations from primary tissue during last month’s ‪TriCon2016‬ in San Francisco

The Tumor Cell Isolation Kit, human enables the enrichment of human tumor cells from primary specimens using MACS® Cell Separation technology.  While depleting tumor associated cells such as lymphocyte subpopulations, fibroblasts, and endothelial cells in a fast and easy protocol, the tumor cells remain untouched, improving any downstream analysis.  Learn more http://goo.gl/Y2gZbO

Leave a Reply